J. Goldman & Co’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-293,864
| Closed | -$1.83M | – | 283 |
|
|
2022
Q4 | $1.83M | Sell |
293,864
-259,146
| -47% | -$1.61M | 0.09% | 138 |
|
|
2022
Q3 | $3.71M | Buy |
+553,010
| New | +$3.71M | 0.18% | 96 |
|
|
2021
Q2 | – | Sell |
-22,738
| Closed | -$638K | – | 328 |
|
|
2021
Q1 | $638K | Sell |
22,738
-19,172
| -46% | -$538K | 0.02% | 259 |
|
|
2020
Q4 | $1.09M | Buy |
41,910
+28,707
| +217% | +$747K | 0.06% | 185 |
|
|
2020
Q3 | $491K | Sell |
13,203
-52,347
| -80% | -$1.95M | 0.03% | 184 |
|
|
2020
Q2 | $3.36M | Buy |
+65,550
| New | +$3.36M | 0.21% | 89 |
|
|
2020
Q1 | – | Sell |
-16,261
| Closed | -$970K | – | 202 |
|
|
2019
Q4 | $970K | Buy |
+16,261
| New | +$970K | 0.07% | 119 |
|
|
2018
Q4 | – | Sell |
-7,552
| Closed | -$335K | – | 175 |
|
|
2018
Q3 | $335K | Sell |
7,552
-85,139
| -92% | -$3.78M | 0.02% | 138 |
|
|
2018
Q2 | $3.63M | Buy |
92,691
+41,444
| +81% | +$1.62M | 0.19% | 94 |
|
|
2018
Q1 | $3.71M | Buy |
51,247
+36,670
| +252% | +$2.65M | 0.16% | 95 |
|
|
2017
Q4 | $960K | Sell |
14,577
-15,443
| -51% | -$1.02M | 0.05% | 142 |
|
|
2017
Q3 | $1.51M | Sell |
30,020
-9,980
| -25% | -$500K | 0.08% | 121 |
|
|
2017
Q2 | $1.85M | Buy |
+40,000
| New | +$1.85M | 0.1% | 108 |
|
|
2017
Q1 | – | Sell |
-162,000
| Closed | -$2.03M | – | 236 |
|
|
2016
Q4 | $2.03M | Buy |
+162,000
| New | +$2.03M | 0.13% | 97 |
|